Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2003
11/04/2003US6641576 Devices for creating vascular grafts by vessel distension using rotatable elements
11/04/2003US6641526 Development of normal offspring from oocytes injected with freeze-dried spermatozoa
11/04/2003CA2106377C Ethanol production by recombinant hosts
11/03/2003CA2427574A1 Plant bioreactor
11/01/2003CA2391438A1 Psp94 diagnostic reagents and assays
10/2003
10/30/2003WO2003089632A1 Gfp-transfected clon pig, gt knock-out clon pig and methods for production thereof
10/30/2003WO2003089631A1 Method for propagating stem cells and/or progenitor cells
10/30/2003WO2003089630A1 Methods for producing immortalised antibodies-secreting cells
10/30/2003WO2003089629A1 Rapid generation of activated mononuclear antigen presenting cells from monocytes
10/30/2003WO2003089628A1 Cell culture method using porous membrane
10/30/2003WO2003089627A1 Translocation dependent complementation for drug screening
10/30/2003WO2003089624A2 Fc receptor homolog, reagents, and uses thereof
10/30/2003WO2003089620A2 Phospholipases, nucleic acids encoding them and methods for making and using them
10/30/2003WO2003089619A2 Placental derived stem cells and uses thereof
10/30/2003WO2003089603A2 Cytokine receptor
10/30/2003WO2003089602A2 Toll-like receptor 11 and toll-like receptor 12
10/30/2003WO2003089592A2 Enhancement of hematopoietic stem cell survival
10/30/2003WO2003089583A2 Tissue specific genes and gene clusters
10/30/2003WO2003089581A2 A method to increase the rate of cell growth
10/30/2003WO2003089580A2 Cancer models
10/30/2003WO2003089578A2 Activation of equine oocytes
10/30/2003WO2003089575A2 Antibodies that specifically bind to tl5
10/30/2003WO2003089573A2 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
10/30/2003WO2003089471A1 Method for producing monoclonal antibodies
10/30/2003WO2003089450A2 Fusion polypeptides and methods for inhibiting microbial adhesion
10/30/2003WO2003088996A2 Lewis y epitope modified polypeptide, or mucin fusion polypetide, tumor vaccines
10/30/2003WO2003088995A2 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
10/30/2003WO2003088935A1 Compositions and methods for inducing new hair follicle formation and hair growth in a desired orientation
10/30/2003WO2003088905A2 Compositions and minimally invasive methods for treating incomplete tissue repair
10/30/2003WO2003088904A2 Screening and therapeutic methods for treating circadian rhythm disorders
10/30/2003WO2003088899A2 Methods for the production of chimeric adeno-associated virus (aav) vectors, compositions of chimeric aav vectors, and methods of use thereof
10/30/2003WO2003088892A2 Transportation of biological matter to a target site in a closed volume for transplantation purposes
10/30/2003WO2003088812A2 Nor-1 and nur77 nuclear receptors as targets for anti-leukemia therapy
10/30/2003WO2003088808A2 Compositions and methods for the diagnosis and treatment of tumor
10/30/2003WO2003088738A1 Regulated ethylene sensitivity to control flower longevity in a plant
10/30/2003WO2003073841A3 Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors
10/30/2003WO2003059923A3 Methods and compositions for generating a genetically modified animal using lentiviral vectors
10/30/2003WO2003055989A3 Cellular compositions and methods of making and using them
10/30/2003WO2003051308A3 Antisense modulation of tfap2c expression
10/30/2003WO2003050233A3 Gene promoters
10/30/2003WO2003049783A3 Device and methods for harvesting tissue samples of known geometry
10/30/2003WO2003047421A3 Methods and reagents for diagnosis and treatment of diabetes
10/30/2003WO2003039481A3 Adipose tissue-derived stromal cells for the repair of corneal and intra-orbital defects and uses thereof
10/30/2003WO2003035693A3 Crystals of cytochrome p450 2c9, structures thereof and their use
10/30/2003WO2003034903A3 Psma antibodies and protein multimers
10/30/2003WO2003031633A3 Adenoviral vector system
10/30/2003WO2003031612A3 Method for determining cell cycle position
10/30/2003WO2003031588A3 Hepatitis c virus vaccine
10/30/2003WO2003031568A3 Intracellular signaling molecules
10/30/2003WO2003027143A3 Gene and protein relating to hepatocellular carcinoma
10/30/2003WO2003024200A3 Production of transgenic birds using stage x primordial germ cells
10/30/2003WO2003020896A3 Production of cultured human mast cells and basophils for high throughput small molecule drug discovery
10/30/2003WO2003016549A3 Nucleic-acid associated proteins
10/30/2003WO2003014310A3 Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof
10/30/2003WO2003014305A3 Eukaryotic cells and method for preserving cells
10/30/2003WO2003010333A3 Methods for gene disruption and uses thereof
10/30/2003WO2003010312A3 Nucleic acid sequences encoding enantioselective amidases
10/30/2003WO2003008618A3 Glucans and glucansucrases derived from lactic acid bacteria
10/30/2003WO2003004661A3 Adenovital vectors with cell type specificity for mesenchymal cells
10/30/2003WO2003000877A3 A soluble complex comprising a retroviral surface glycoprotein
10/30/2003WO2002099117A3 Nucleic acid regulatory sequences and uses therefor
10/30/2003WO2002099041A3 Ces2s as modifiers of the p53 pathway and methods of use
10/30/2003WO2002095038A3 Vectors for enhanced expression of vegf for disease treatment
10/30/2003WO2002094876A3 Methods and compositions for treating respiratory mucin production associated disease conditions
10/30/2003WO2002092634A3 Specific antibodies for histamine receptor subclasses
10/30/2003WO2002090511A3 Method for the isolation of stem cells by immuno-labeling with hla/mhc gene product marker
10/30/2003WO2002084294A3 Gastrointestinal glutathione peroxidase in hepatitis c virus infections
10/30/2003WO2002083945A3 Diagnosis and treatment of cancer: i
10/30/2003WO2002073204A3 Cell-based detection and differentiation of disease states
10/30/2003WO2002072851A3 Lentiviral packaging constructs
10/30/2003WO2002072758A3 Cytochrome p450s and uses thereof
10/30/2003WO2002068617A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/30/2003WO2002066612A3 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
10/30/2003WO2002063024A3 Sustained totipotent culture of selected monocot genera
10/30/2003WO2002062965A3 Method for identifying intercellular protein factors
10/30/2003WO2002059327A3 Sulfatases and methods of use thereof
10/30/2003WO2002059283A3 Nucleic acid modification enzymes
10/30/2003WO2002055704A3 Proteins, polynucleotides encoding them and methods of using the same
10/30/2003WO2002053703A3 Aav2 vectors and methods
10/30/2003WO2002050243A3 The use of ecm degrading enzymes for the improvement of cell transplantation
10/30/2003WO2002044361A8 Eukaryotic expression libraries based on double lox recombination and methods of use
10/30/2003WO2002036749A3 Postmortem stem cells
10/30/2003WO2002034783A3 Transmembrane proteins
10/30/2003WO2002022819A3 Calcium binding proteins
10/30/2003WO2002010414A9 Expression of biologically active polypeptides in duckweed
10/30/2003WO2001085995A3 Identification of neural defects associated with the nucleosom al assembly protein 1l2 gene
10/30/2003US20030204875 Novel agrobacterium-mediated plant transformation method
10/30/2003US20030204874 Genetically engineered plants coding abscisic acid responsive element binding factor (ABF) for generating dought and environmental stress resistant plants
10/30/2003US20030204873 Generating genetically engineered herbicide resistant monocotyledons
10/30/2003US20030204871 Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and related fatty acids having a modification at the delta-9 position
10/30/2003US20030204863 Nav2 channel gene-deficient non-human animals
10/30/2003US20030204862 Inbred embryonic stem-cell derived mice
10/30/2003US20030204860 Cloning non-human mammals through nuclear transfer/ transplantation
10/30/2003US20030204128 Magnetic embryo transfer
10/30/2003US20030204076 Antisense modulation of vascular endothelial growth factor receptor-1 expression
10/30/2003US20030204072 Comprises receptor protein tyrosine kinase (rPTK) for diagnosing and treating kidney or neurodegenerative diseases
10/30/2003US20030204071 109 human secreted proteins
10/30/2003US20030204069 Segments of the human gene for telomerase reverse transcriptase
10/30/2003US20030204065 Comprises peptidoglycan recognition protein (PGRP) for diagnosis and treatment of blood and tumor disorders
10/30/2003US20030204062 Immunoglobulin specific for osteoclast hydrolase (TRACP5AL) for use in the diagnosis and treatment of bone disorders
1 ... 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 ... 1827